News

Prime Medicine Focuses on Genetic Liver Diseases, Partnered Programs After Positive CGD Data
Prime Medicine Inc. (NASDAQ:PRME) is one of the best hot stocks to buy according to Wall Street analysts. In May, Prime ...
Physician's Weekly18h
High Mortality With ECMO in Cystic Fibrosis Exacerbations
ECMO use in cystic fibrosis with severe respiratory failure showed limited survival, highlighting the need for cautious ...
Small Molecule CFTR Modulators Market To Reach $8.45 Billion By 2025, Projected To Grow At 13% CAGR
The small molecule CFTR modulators market targets cystic fibrosis treatment, driven by innovative therapies, rising prevalence ...